Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP972240priorityCriticalpatent/ECSP972240A/en
Publication of ECSP972240ApublicationCriticalpatent/ECSP972240A/en
La invención se relaciona con formulaciones de aereosol en suspensión que exhiben tamaños de partículas estables, que contienen furoato de mometasona de aproximadamente 1 a aproximadamente 10 por ciento por peso de etanol y 1,1,1,2,3,3 -heptafluoropropano como impelente. Se puede incluir asi mismo surfactante, tal como ácido olóico. Estas formulaciones son adecuadas para utilizar en nubulizadores de dosis medida.The invention relates to suspension aerosol formulations exhibiting stable particle sizes, containing mometasone furoate of from about 1 to about 10 weight percent ethanol and 1,1,1,2,3,3-heptafluoropropane as an impeller. . Surfactant, such as oleic acid, may also be included. These formulations are suitable for use in metered dose clouders.
ECSP9722401997-08-271997-08-27
MOMETHASONE FUROATE AEROSOL FORMULATIONS WITHOUT CHLOROFLUOROCARBES
ECSP972240A
(en)
PROCESS FOR THE SYNTHESIS OF PURE D-(17α)-13-ETHYL-17-HYDROXY-18,19-DINORPREGN-4-ENE-20-YNE-3-ONE-3E- AND -3Z-OXIME ISOMERS AND THE MIXTURE OF ISOMERS, AND USE OF THOSE ISOMERS